Panacea Biotech collaborates with Refana to develop COVID-19 vaccine
Panacea Biotech collaborates with Refana to develop COVID-19 vaccine 
News in Brief

Panacea Biotech collaborates with Refana to develop COVID-19 vaccine

India Global Business Staff

Panacea biotech in partnership with Refana aims to manufacture over 500 million doses of the vaccine candidate.

Panacea Biotech Ltd has partnered with US based Refana Inc to set up a joint venture firm in Ireland to develop potential vaccine for COVID-19.

Under the partnership, Panacea Biotech will be responsible for product development and commercial manufacturing. The two firms' joint venture company will undertake clinical development and make regulatory submission globally. After the approval, Refana and Panacea will undertake sales and distribution of the COVID vaccine in their respective territories.

Rajesh Jain, Managing Director, Panacea Biotec, said: “The world needs a vaccine that is safe, effective, and scalable in a Current Good Manufacturing Practice (cGMP) compliant manufacturing facility that has sizeable capacity and capability to cater to global demand.”

Jain said the two firms aim to manufacture over 500 million doses of the vaccine candidate, with over 40 million doses expected to be available early next year.

In a move that renewed hope in India’s civil aviation circles, and sent waves of optimism in business circles, the Tata Group acquired beleaguered national carrier Air India for $2.4 billion last week. The transaction will be completed by December 2021.

Tata Group’s take over of Air India puts the competition on alert

Crowds at a wholesale vegetable market in Kolkata. According to the RBI, the real GDP growth for the first quarter of FY 2022-23 is projected at 17.2 per cent.

RBI says growth impulses strengthening, inflation trajectory favourable

Gadkari focuses on alternate fuels, EVs in clean transport push

India, UAE march towards Comprehensive Economic Partnership Agreement

India’s new Parliament on track to host 2022 Winter Session